NCT07531823

Brief Summary

This study aimed to evaluate the influence of amla (Emblica officinalis) on patients with chronic generalized periodontitis, using a single-blind, randomized controlled study design.

  1. 1.At baseline, all participants fulfilling the I/E criteria would be randomized into Arm I or II.
  2. 2.All participants in Arm I and II would undergo scaling and root planing (SRP).
  3. 3.After 1 month, Arm I participants would receive adjunct amla for 2 weeks, and Arm II participants would receive no treatment.
  4. 4.Both arms would be followed until the end of 6 months and evaluated for clinical and biochemical parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 15, 2026

Completed
Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 6, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

chronic periodontitisEmblica officinalis (amla)antioxidant

Outcome Measures

Primary Outcomes (5)

  • Improvement in clinical parameters (plaque index)

    Improvement in plaque index

    1, 3 and 6 months

  • Improvement in clinical parameters (gingival index)

    Improvement in gingival index

    1,3 and 6 months

  • Improvement in clinical parameters (bleeding index)

    Improvement in bleeding index

    1,3 and 6 months

  • Improvement in clinical parameters (probing pocket depth)

    Improvement in probing pocket depth

    1,3 and 6 months

  • Improvement in clinical parameters (clinical attachment level)

    Improvement in clinical attachment level

    1,3 and 6 months

Secondary Outcomes (4)

  • Changes in antioxidant levels (Malondialdehyde) in saliva and serum

    6 months

  • Changes in antioxidant levels (glutathione) in saliva and serum

    6 months

  • Changes in anti-inflammatory marker levels (CRP) in serum and saliva

    6 months

  • Changes in anti-inflammatory marker levels (TNF-alpha) in serum and saliva

    6 months

Study Arms (2)

Scaling and root planing + Amla

ACTIVE COMPARATOR

Arm I - This group of chronic generalized periodontitis patients would receive the standard of care i.e. scaling and root planing, followed by a full amla berry daily for 2 weeks.

Dietary Supplement: Scaling and root planing + Amla

Scaling and root planing

SHAM COMPARATOR

Arm II - This group of chronic generalized periodontitis patients received the standard of care i.e. scaling and root planing

Other: Scaling and root planing

Interventions

Chronic generalized patients were randomly assigned to Arm I and Arm II. Arm I participants underwent scaling and root planing followed by consumption of a whole amla berry.

Also known as: Emblica officinalis
Scaling and root planing + Amla

Chronic generalized patients were randomly assigned to Arm I and Arm II. Arm II participants underwent scaling and root planing only.

Scaling and root planing

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who have at least 20 remaining teeth, with chronic generalized periodontitis, as defined as \> 30 % sites involved (extent) and with moderate to severe involvement (severity) as characterized by \> 2 interproximal sites with clinical attachment loss (CAL) \> 4mm (not on the same tooth) AND/OR \> 5 mm, probing depth (not on the same tooth) AND/OR \> 2 interproximal sites with CAL \> 6 mm AND 1 interproximal site with PD \> 5mm.
  • Systemically healthy patients

You may not qualify if:

  • Medically compromised patients
  • Smokers
  • Pregnant and lactating women
  • Patients on cholesterol-lowering medication
  • Patients who had received any antimicrobial therapy in the past 2 months, on ongoing antimicrobial therapy, or would receive antimicrobials during the course of the study.
  • Patients who had undergone any periodontal surgery in the past 6 months
  • Patients with a high caries index
  • Patients with severe tooth hypersensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mahatma Gandhi Postgraduate Institute of Dental Sciences

Puducherry, Puducherry, 605006, India

Location

MeSH Terms

Conditions

Chronic Periodontitis

Interventions

Tooth ExfoliationRoot Planing

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive Dentistry

Study Officials

  • Grace T Paul, MDS

    Mahatma Gandhi Postgraduate Institute of Dental Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigator and outcome assessor were not aware of the arms or the intervention received. The additional intervention (amla dispensing) was conducted by another member, not involved in the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study is a single-blind, randomized controlled trial, where one arm receives scaling and root planing along with amla (after 1 month of SRP). The other arm receives only scaling and root planing.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 6, 2026

First Posted

April 15, 2026

Study Start

March 20, 2020

Primary Completion

March 15, 2022

Study Completion

September 15, 2022

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Hospital has a SOP for data Sharing. The request should come through a proper channel, only then the individual patient data can be shared.

Locations